Leora Horn
-
Cancer patient chooses Nashville for VICC care and the Nashville Predators
Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center. Read MoreJun 13, 2017
-
Horn to lead lung cancer combination therapy trial
Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer. Read MoreMar 30, 2017
-
VICC trial putting lung cancer therapy to the test
Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis. Read MoreOct 20, 2016
-
VICC’s Horn lands Team Leadership Award from NCI
Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI). Read MoreNov 19, 2015
-
Fundraiser featuring Reba McEntire, Time Jumpers benefits lung cancer research
"Dawn Sears and Friends," a fundraiser to benefit lung cancer research at the Vanderbilt-Ingram Cancer Center, is scheduled for Nov. 30 at Depot Square in Gallatin, Tennessee. Reba McEntire, The Time Jumpers, Riders in the Sky and Olympic figure skating great Scott Hamilton will be featured. Read MoreNov 13, 2014
-
Averting a future oncologist shortage
Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists. Read MoreNov 11, 2011